Reactive Arthritis

Area of Science:

• Rheumatology
• Immunology
• Infectious Diseases

Background:

• Reactive arthritis is a spondyloarthropathy characterized by an infectious trigger followed by inflammatory arthritis.
• The pathogenesis involves complex interactions between host susceptibility and microbial factors.
• Understanding these mechanisms is crucial for diagnosis and treatment.

Purpose of the Study:

• To review the current understanding of reactive arthritis, including its triggers, diagnostic criteria, and therapeutic approaches.
• To discuss the role of antibiotics and emerging therapies like tumor necrosis factor alpha inhibitors.
• To highlight the variable clinical course and potential for extraarticular manifestations.

Main Methods:

• Literature review of reactive arthritis, spondyloarthropathies, and related infectious triggers.
• Analysis of diagnostic approaches combining clinical presentation and microbiological confirmation.
• Evaluation of current and evolving therapeutic strategies, including antibiotic and immunomodulatory treatments.

Main Results:

• Diagnosis requires a compatible clinical syndrome and pathogen confirmation.
• Antibiotic therapy is beneficial for Chlamydia-induced reactive arthritis.
• The efficacy of antibiotics for enteric pathogen-triggered arthritis is uncertain, and tumor necrosis factor alpha inhibitor therapy is under investigation.

Conclusions:

• Reactive arthritis is an infection-triggered inflammatory condition with diverse clinical outcomes.
• Treatment strategies are evolving, with specific considerations for different causative pathogens.
• While many cases resolve, some patients experience chronic or extraarticular disease, necessitating ongoing research into effective management.